Scolaris Content Display Scolaris Content Display

Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non‐cardiac surgery

This is not the most recent version

References

Additional references

Berger 2010

Berger PB, Kleiman NS, Pencina MJ, Hsieh WH, Steinhubl SR, Jeremias A, et al. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug‐eluting stent placement: results from the EVENT (Evaluation of Drug‐Eluting Stents and Ischemic Events) Registry. Journal of the American College of Cardiology. Cardiovascular Interventions 2010;3(9):920‐7. [PUBMED: 20850090]

Covidence [Computer program]

Covidence. www.covidence.org (accessed 24 May 2016).

Devereaux 2016

Devereaux PJ, Eikelboom J. Insights into myocardial infarction after noncardiac surgery in patients with a prior coronary artery stent. British Journal of Anaesthesia 2016;116(5):584‐6. [PUBMED: 27106960]

Egger 1997

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical research ed.) 1997;315(7109):629‐34. [PUBMED: 9310563]

Endnote [Computer program]

Thomson Reuters. Endnote X5. www.endnote.com, 2011 (accessed 2016).

Fleisher 2014

Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;130(24):2215‐45. [PUBMED: 25085962]

Guyatt 2008

Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck‐Ytter Y, Schunemann HJ, et al. What is "quality of evidence" and why is it important to clinicians?. BMJ (Clinical research ed.) 2008;336(7651):995‐8. [PUBMED: 18456631]

Guyatt 2011

Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence ‐ inconsistency. Journal of Clinical Epidemiology 2011;64(12):1294‐302. [PUBMED: 21803546]

Hawn 2013

Hawn MT, Graham LA, Richman JS, Itani KM, Henderson WG, Maddox TM. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 2013;310(14):1462‐72. [PUBMED: 24101118]

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org.

Keeling 2016

Keeling D, Campbell Tait R, Watson H. Peri‐operative management of anticoagulation and antiplatelet therapy. http://www.b‐s‐h.org.uk/guidelines/guidelines/peri‐operative‐management‐of‐anticoagulation‐and‐antiplatelet‐therapy/ (accessed 22 November 2016).

Korte 2011

Korte W, Cattaneo M, Chassot PG, Eichinger S, von Heymann C, Hofmann N, et al. Peri‐operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the Working Group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the Working Group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (OGARI) and the Working Group on Thrombosis of the European Society for Cardiology (ESC). Thrombosis and Haemostasis 2011;105(5):743‐9. [PUBMED: 21437351]

Levine 2016

Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST‐elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST‐elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2016;133(11):1135‐47. [PUBMED: 26490017]

Liberati 2009

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology 2009;62(10):e1‐34. [PUBMED: 19631507]

Mantz 2011

Mantz J, Samama CM, Tubach F, Devereaux PJ, Collet JP, Albaladejo P, et al. Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non‐cardiac surgery: the multicentre, randomized, blinded, placebo‐controlled, STRATAGEM trial. British Journal of Anaesthesia 2011;107(6):899‐910. [PUBMED: 21873632]

NICE 2010

National Institute for Health and Clinical Excellence (NICE). Clopidogrel and modified‐release dipyridamole for the prevention of occlusive vascular events. https://www.nice.org.uk/guidance/ta210;2010.

Oprea 2013

Oprea AD, Popescu WM. Perioperative management of antiplatelet therapy. British Journal of Anaesthesia 2013;111 Suppl 1:i3‐17. [PUBMED: 24335397]

Oscarsson 2010

Oscarsson A, Gupta A, Fredrikson M, Jarhult J, Nystrom M, Pettersson E, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. British Journal of Anaesthesia 2010;104(3):305‐12. [PUBMED: 20150346]

RevMan 5.3 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Rossini 2014

Rossini R, Musumeci G, Visconti LO, Bramucci E, Castiglioni B, De Servi S, et al. Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non‐cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2014;10(1):38‐46. [PUBMED: 24832636]

Singla 2012

Singla S, Sachdeva R, Uretsky BF. The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention. Journal of the American College of Cardiology 2012;60(20):2005‐16. [PUBMED: 23083781]

Sorensen 2009

Sorensen R, Hansen ML, Abildstrom SZ, Hvelplund A, Andersson C, Jorgensen C, et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet (London, England) 2009;374(9706):1967‐74. [PUBMED: 20006130]

Wasowicz 2016

Wasowicz M, Syed S, Wijeysundera DN, Starzyk L, Grewal D, Ragoonanan T, et al. Effectiveness of platelet inhibition on major adverse cardiac events in non‐cardiac surgery after percutaneous coronary intervention: a prospective cohort study. British Journal of Anaesthesia 2016;116(4):493‐500. [PUBMED: 26888800]

Wijeysundera 2012

Wijeysundera DN, Wijeysundera HC, Yun L, Wasowicz M, Beattie WS, Velianou JL, et al. Risk of elective major noncardiac surgery after coronary stent insertion: a population‐based study. Circulation 2012;126(11):1355‐62. [PUBMED: 22893606]